EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosomal PDL1 Suppresses the Anticancer Activity of CD8 + T Cells in Hepatocellular Carcinoma

Qi Hu, Shuai Chen, Rilin Deng, Hongyu Deng, Mingjing Peng, Xiaohong Wang, Shun Deng, Jinfeng Wang, Biaoming Xu, Yan Xu, Haizhen Zhu, Jinhai Zheng und 2 weitere

Analytical Cellular Pathology · 2024-01 · 2024 (1)

DOI: 10.1155/2024/1608582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, online erschienen am 09.10.2024. Verfasst von Qi Hu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD8-Positive T-Lymphocytes, Exosomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor microenvironment (TME) is essential for the development and progression of hepatocellular carcinoma (HCC). Exosomes participate in constructing TME by passing biological information, but the regulatory effect of PDL1 in exosomes on anticancer activity of CD8 + T cells in HCC still needs to be further explored. In this study, high level of PDL1 was found in plasma exosomes of HCC patients, which turned out to be significantly associated with the increased number of tumor nodules, the upregulated level of serum AFP, the raised tendency of TNM stage, and the poor prognosis of HCC. The expression of CD8 may be inhibited in HCC that is characterized with high level of PDL1, and the protein level of exosomal PDL1 was determined by intracellular PDL1 abundance. High level of exosomal PDL1 inhibited the proliferation and activation of CD8 + T cells, but exhibited limited effect on the proliferation of hepatic cancer cells. Moreover, the growth of tumors formed by hepatic cancer cells Hepa1–6 in C57L mice was significantly promoted by the exosomal PDL1, which might be caused by the inhibitory effect of exosomal PDL1 on CD8 + T cells. Thus, exosomal PDL1 promotes the development and progression of HCC through inhibiting the anticancer activity of CD8 + T cells. This study provides sights for understanding the oncogenic role of PDL1 and a reasonable explanation for the low efficacy of anti‐PD1/PDL1 immunotherapies in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCD8-Positive T-LymphocytesExosomesB7-H1 AntigenCell ProliferationAnimalsHumansMaleMiddle AgedFemaleCell Line, TumorMice, Inbred C57BLTumor MicroenvironmentMice

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, Hunan, China.
  • Hunan Normal University School of Medicine, Changsha 410013, Hunan, China.
  • Department of Gastroduodenal and Pancreatic Surgery, Translational Medicine Joint Research Center of Liver Cancer, Laboratory of Digestive Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya Sc…
  • Key Laboratory of Tropical Translational Medicine of Ministry of Education, Department of Pathogen Biology, School of Basic Medicine and Life Science, Department of Clinical Laboratory of the Second Affiliated Hospital,…
  • School of Biomedical Sciences, Hunan University, Changsha 410082, Hunan, China.

ORCID-Profile: Man Xia, Chaohui Zuo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hu, Q., Chen, S., Deng, R., Deng, H., Peng, M., Wang, X., Deng, S., Wang, J., Xu, B., Xu, Y., Zhu, H., Zheng, J., Xia, M., & Zuo, C. (2024). Exosomal PDL1 Suppresses the Anticancer Activity of CD8 + T Cells in Hepatocellular Carcinoma. Analytical Cellular Pathology, 2024(1). https://doi.org/10.1155/2024/1608582

Vancouver

Hu Q, Chen S, Deng R, Deng H, Peng M, Wang X, et al. Exosomal PDL1 Suppresses the Anticancer Activity of CD8 + T Cells in Hepatocellular Carcinoma. Analytical Cellular Pathology. 2024;2024(1). doi:10.1155/2024/1608582

BibTeX
@article{Hu2024,
  author = {Hu, Qi and Chen, Shuai and Deng, Rilin and Deng, Hongyu and Peng, Mingjing and Wang, Xiaohong and Deng, Shun and Wang, Jinfeng and Xu, Biaoming and Xu, Yan and Zhu, Haizhen and Zheng, Jinhai and Xia, Man and Zuo, Chaohui},
  title = {Exosomal PDL1 Suppresses the Anticancer Activity of CD8 + T Cells in Hepatocellular Carcinoma},
  journal = {Analytical Cellular Pathology},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/1608582}
}
Kostenlos starten →